Virtu Financial LLC Novavax Inc Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$69.73 - $142.9 $467,539 - $958,144	-6,705 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$134.56 - $217.97 $1.34 Million - $2.17 Million	-9,961 Reduced 59.77%	6,705 $959,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $2.96 Million - $4.51 Million	16,666 New	16,666 $3.46 Million
Q2 2021 Sep 17, 2021	SELL	$121.0 - $257.67 $2.43 Million - $5.18 Million	-20,089 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$112.98 - $319.93 $2.27 Million - $6.43 Million	20,089 New	20,089 $3.64 Million
Q3 2020 Dec 11, 2020	SELL	$79.44 - $178.51 $5.3 Million - $11.9 Million	-66,705 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$13.86 - $83.61 $330,976 - $2 Million	23,880 Added 55.76%	66,705 $5.56 Million
Q4 2019 Feb 04, 2020	SELL	$3.69 - $5.22 $27,859 - $39,411	-7,550 Reduced 14.99%	42,825 $170,000
Q3 2019 Nov 20, 2019	SELL	$4.02 - $7.84 $83,189 - $162,240	-20,694 Reduced 29.12%	50,375 $253,000
Q2 2019 Aug 13, 2019	BUY	$4.93 - $12.2 $350,370 - $867,041	71,069 New	71,069 $417,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.